8th World Nephrology Conference
Sao Paulo, Brazil
Federal University of Ceara, Brazil
Title: Modulation of guanylin pathway by enalapril in 5/6 nephrectomized rats
Biography: Pedro Henrique Sá Costa
Chronic kidney disease (CKD) is characterized by loss usually slow, progressive and irreversible of renal function. In this context, more studies are necessary for establishment of a link between DRC and regulation of natriuretic peptides, as guanylin (Gn), uroguanylin (UGn) and atrial natriuretic peptide (ANP), and the effect of angiotensin II (Ang II) on regulation of these peptides. Thus, we sought to evaluate a possible modulation of the guanylin by enalapril in the 5/6 nephrectomy model (nx5/6). We used male Wistar rats, weighing between 250-300g. The animals were divided into 4 groups (n = 8): untreated control group treated or not with enalapril (10 mg/kg oral) (SHAM and SHAM+E) and group subjected to nx5/6 treated or not with enalapril (10 mg / kg oral) (Nx and Nx+E). Kidney samples were sent for histological analysis and evaluation of mRNA expression of Gn, UGn, ANP and membrane guanylate cyclase receptors, GC-A and GC-C, and the clearance receptor (NPR-C). Nx showed increased intrarenal gene expression of Gn (Nx=13.92 ± 5.13; SHAM=1.08 ± 0.20) UGn (Nx= 12.77 ± 7.00; SHAM=1.04 ± 0.13), GC-A (Nx=5.91 ± 1.36; SHAM=1.06 ± 0.17) and NPR-C (Nx=7.84 ± 1.72; SHAM =1.15 ± 12.27), and Nx+E had reduced genes for UGn (Nx+E= 0.10 ± 0.03; Nx = 1.75 ± 0.96), GC-A (Nx + E= 0.031 ± 0.01; Nx= 1.18 ± 0.27) and NPR-C (Nx+E= 0,03 ± 0.01; Nx= 1.8 ± 0.24) when compared to Nx. Together, these data suggest a hyperactivation the path of guanylin in CKD, and modulation of this peptide class by Ang II.